| Angiotensin II | IC50 | 0.08 [1], 2.5 [2] |
| Losartan | IC50 | 19.0 [1], 10000.0 [2] |
| Saralasin | IC50 | 0.53 [1], 1.32 [2] |
| Saralasin | Ki | 0.15 [1], 0.38 [2] |
| Butyl N-[3-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | IC50 | 2.0 [1] |
| Butyl N-[3-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 2.8 [1] |
| Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-propylphenyl]sulfonylcarbamate | IC50 | 4.2 [1], 6.1 [2] |
| Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-propylphenyl]sulfonylcarbamate | Ki | 1.5 [1] |
| PD 123319 ditrifluoroacetate | IC50 | 6.9 [1], 8.3 [2], 34.0 [3] |
| Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | IC50 | 0.7 [1] |
| Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 2.1 [1] |
| (3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-3-(4-aminophenyl)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 0.7 [1], 0.9 [2], 1.4 [3], 2.1 [4] |
| Olodanrigan | IC50 | 0.58 [1], 0.6 [2] |
| Olodanrigan | Ki | 39.5 [1] |
| Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-[(3-methoxyphenyl)methyl]phenyl]sulfonylcarbamate | IC50 | 101.0 [1] |
| Butyl N-[2-[4-(imidazol-1-ylmethyl)phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 0.6 [1], 0.7 [2] |
| Butyl N-[3-[3-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 17.8 [1], 270.0 [2] |
| (Sar1,Ile8)-Angiotensin II | Ki | 0.14 [1] |
| N-[4-Oxo-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]quinazolin-6-yl]-N-pentylbenzamide | IC50 | 0.7 [1], 7.0 [2] |
| Butyl N-[2-[3-(imidazol-1-ylmethyl)phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 12.3 [1] |
| Tert-butyl N-[2-[4-[[1-[2-bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 0.12 [1], 3.4 [2] |
| (3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-4-[2-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-2-[(4-hydroxyphenyl)methyl]-3-oxo-2,5-dihydro-1H-1,4-benzodiazepin-7-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 3.0 [1] |
| (3S)-3-Amino-4-[[(2S)-1-[[(2S)-4-[2-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-2-[(4-hydroxyphenyl)methyl]-3-oxo-2,5-dihydro-1H-1,4-benzodiazepin-7-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 10000.0 [1] |
| 2-Propyl-5-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | IC50 | 60.0 [1] |
| Tert-butyl N-[2-[4-[[3-butyl-1-[2-chloro-5-[(2-ethoxyacetyl)amino]phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 1.2 [1], 2.5 [2] |
| Tert-butyl N-[2-[4-[[3-butyl-5-oxo-1-[5-(pentanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 0.88 [1], 3.8 [2] |
| Tert-butyl N-[2-[4-[[1-(5-acetamido-2-chlorophenyl)-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]-4-propylphenyl]sulfonylcarbamate | IC50 | 0.82 [1], 12.0 [2] |
| N-[2-[4-[[3-Butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-chlorobenzamide | IC50 | 1.3 [1], 3.5 [2] |
| (2S,3S)-2-[[3-(Imidazol-1-ylmethyl)benzoyl]amino]-3-methylpentanoic acid;2,2,2-trifluoroacetic acid | Ki | 47000.0 [1], 110000.0 [2] |
| (2-Benzoylphenyl)methyl 5-ethyl-3-[[2-fluoro-4-[2-(3-methylbutoxycarbonylsulfamoyl)phenyl]phenyl]methyl]-2-propylimidazole-4-carboxylate | IC50 | 0.69 [1], 0.7 [2] |
| N-[2-[4-[[1-(5-Acetamido-2-chlorophenyl)-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]-4-propylphenyl]sulfonyl-2-chlorobenzamide | IC50 | 0.48 [1], 17.0 [2] |
| 1,4-Di(diphenylcarbamoyl)-(2S)-hexahydro-2-pyrazinecarboxylic acid | IC50 | 0.89 [1], 1.5 [2] |
| Losartan potassium | IC50 | 10000.0 [1] |
| Candesartan | Ki | 10000.0 [1] |
| Telmisartan | IC50 | 0.33 [1] |
| Miconazole | Ki | 7779.0 [1] |
| (Sar1)-Angiotensin II | Ki | 0.18 [1] |
| 4'-((2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid | IC50 | 200.0 [1] |
| 2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine | IC50 | 0.2 [1] |
| Potassium;2-butyl-5-methylsulfanyl-3-[[4-[2-(propylcarbamoylsulfamoyl)phenyl]phenyl]methyl]imidazole-4-carboxylate | IC50 | 920.0 [1] |
| Pratosartan | IC50 | 10000.0 [1] |
| (6S)-1-[(4-Amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid | IC50 | 66.0 [1] |
| 4-Ethyl-2-propyl-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylimidazole-5-carboxylic acid | IC50 | 1000.0 [1] |
| 2-[4-[[2-Butyl-6-(cyclohexylcarbamoylamino)benzimidazol-1-yl]methyl]phenyl]benzoic acid | Ki | 480.0 [1] |
| 2-[[4-[[2-Butyl-6-[methylcarbamoyl(pentyl)amino]benzimidazol-1-yl]methyl]phenyl]carbamoyl]-3,6-dichlorobenzoic acid | Ki | 730.0 [1] |
| CID 5311416 | Ki | 10000.0 [1] |
| (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-Amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid | IC50 | 1.74 [1] |
| 2-(2,2-Diphenylacetyl)-6-methoxy-5-phenylmethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | IC50 | 2.4 [1] |
| Nocathiacin acid | IC50 | 1120.0 [1] |
| 3-[2-Butyl-4-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]quinazolin-6-yl]-1-methyl-1-propan-2-ylurea | IC50 | 4500.0 [1] |
| N-Butyloxycarbonyl-2-(4-imidazol-1-ylmethylphenyl)-4-butoxybenzenesulfonamide | Ki | 0.5 [1] |
| 2-Ethyl-7-methyl-5-(2-methylpropyl)-3-[(1S)-5-[2-(2H-tetrazol-5-yl)phenyl]-2,3-dihydro-1H-inden-1-yl]imidazo[4,5-b]pyridine | Ki | 10000.0 [1] |
| Angiotensin II, ala(8)- | IC50 | 0.21 [1] |
| Tert-butyl N-[2-[4-[[3-butyl-1-[2-chloro-5-(propanoylamino)phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonylcarbamate | IC50 | 5.8 [1] |
| Butyl N-[2-[3-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 8.2 [1] |
| N-(Benzenesulfonyl)-2-[4-[[2-butyl-4-chloro-5-(hydroxymethyl)imidazol-1-yl]methyl]phenyl]benzamide | IC50 | 140.0 [1] |
| 2-[(1S,18S,21E,28S,29S,30S)-30-[(2S,4S,5R,6S)-5-(Dimethylamino)-4-hydroxy-4,6-dimethyloxan-2-yl]oxy-9,52-dihydroxy-18-[(1R)-1-hydroxyethyl]-21-(1-methoxyethylidene)-16,19,26,31,42,46-hexaoxo-32,43,54-trioxa-3,13,23,49-tetrathia-7,17,20,27,45,51,52,55,56,57-decazadecacyclo[26.16.6.229,40.12,5.112,15.122,25.138,41.147,50.06,11.034,39]heptapentaconta-2(57),4,6,8,10,12(56),14,22(55),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-N-(3-morpholin-4-ylpropyl)-1,3-thiazole-4-carboxamide | IC50 | 260.0 [1] |
| 3-Butyl-1-oxido-2-[4-[2-(2H-tetrazol-5-yl)phenyl]phenoxy]quinoxalin-1-ium | Ki | 4.5 [1] |
| (3R)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | IC50 | 0.08 [1] |
| 2-[(1S,18S,21E,28S,29S,30S)-30-[(2S,4S,5R,6S)-5-(Dimethylamino)-4-hydroxy-4,6-dimethyloxan-2-yl]oxy-52-hydroxy-18-[(1R)-1-hydroxyethyl]-9-methoxy-21-(1-methoxyethylidene)-16,19,26,31,42,46-hexaoxo-32,43,54-trioxa-3,13,23,49-tetrathia-7,17,20,27,45,51,52,55,56,57-decazadecacyclo[26.16.6.229,40.12,5.112,15.122,25.138,41.147,50.06,11.034,39]heptapentaconta-2(57),4,6,8,10,12(56),14,22(55),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-N-(3-morpholin-4-ylpropyl)-1,3-thiazole-4-carboxamide | IC50 | 5070.0 [1] |
| (3S)-3-Amino-4-[[(2S)-1-[[(4R)-2-[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-[(4-hydroxyphenyl)methyl]-3-oxo-1,4-dihydroisoquinolin-7-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 10000.0 [1] |
| 2-[4-[[4-Methyl-6-(2-phenylethylcarbamoyl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid | IC50 | 10000.0 [1] |
| 5-Methylsulfanyl-2-propyl-3-[[4-[2-(propylcarbamoylsulfamoyl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | IC50 | 775.0 [1] |
| 2-Butyl-5-methylsulfanyl-3-[[4-[2-(propylcarbamoylsulfamoyl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | IC50 | 920.0 [1] |
| Tert-butyl N-[2-[4-[[3-butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonylcarbamate | IC50 | 18.0 [1] |
| Methyl 5-ethyl-3-[[2-fluoro-4-[2-(3-methylbutoxycarbonylsulfamoyl)phenyl]phenyl]methyl]-2-propylimidazole-4-carboxylate | IC50 | 1.0 [1] |
| 2-Cyclopropylethyl N-[2-[4-[[2-ethyl-6-[[methyl(propan-2-yl)carbamoyl]amino]-4-oxoquinazolin-3-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 6.2 [1] |
| 3-Butyl-1-chloro-5-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]-5,6-dihydroimidazo[1,5-a]pyridine-7-carboxylic acid | IC50 | 10.0 [1] |
| Propan-2-yl N-[2-[4-[[3-butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.7 [1] |
| Tert-butyl N-[2-[4-[[1-[2-bromo-5-(butylcarbamoyl)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 3.7 [1] |
| N-[2-[4-[[3-Butyl-1-[2-chloro-5-(propanoylamino)phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-chlorobenzamide | IC50 | 3.1 [1] |
| Tert-butyl N-[2-[4-[[1-[2-bromo-5-(propanoylamino)phenyl]-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.3 [1] |
| Tert-butyl N-[2-[4-[[1-[5-(butylcarbamoyl)-2-(trifluoromethyl)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.6 [1] |
| N-[2-[4-[[1-[2-Bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2,5-difluorobenzamide | IC50 | 1.5 [1] |
| (3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxo-4-sulfanylbutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-4-sulfanylbutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 2.1 [1] |
| Tert-butyl N-[2-[4-[[1-(5-benzamido-2-chlorophenyl)-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 10.0 [1] |
| Propan-2-yl N-[2-[4-[[1-[2-bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 1.1 [1] |
| Tert-butyl N-[2-[4-[[3-butyl-1-[5-[(2-ethoxyacetyl)amino]-2-(trifluoromethyl)phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.2 [1] |
| 2-[4-[(2-Butyl-4-oxo-5H-imidazo[4,5-c]pyridin-3-yl)methyl]phenyl]benzoic acid | IC50 | 20.0 [1] |
| Tert-butyl N-[2-[4-[[1-[2-bromo-5-(propanoylamino)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 1.4 [1] |
| N-[2-[4-[[1-[2-Bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-fluorobenzamide | IC50 | 0.64 [1] |
| N-Butyl-3-[3-butyl-4-[[4-[2-[(2-chlorobenzoyl)sulfamoyl]phenyl]-2-fluorophenyl]methyl]-5-oxo-1,2,4-triazol-1-yl]-4-chlorobenzamide | IC50 | 3.7 [1] |
| Tert-butyl N-[2-[4-[[1-[5-benzamido-2-(trifluoromethyl)phenyl]-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 6.3 [1] |
| N-Iso-Butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide | Ki | 37.0 [1] |
| Tert-butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 63.0 [1] |
| N-Butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-butylthiophene-2-sulfonamide | Ki | 5.0 [1] |
| Ethyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 10.0 [1] |
| N-Iso-propyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide | Ki | 75.0 [1] |
| 2-Butoxy-N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylacetamide | Ki | 1.0 [1] |
| N-Butylsulfonyl-3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-carboxamide | Ki | 79.0 [1] |
| Butyl N-[3-[4-[(2-ethylbenzimidazol-1-yl)methyl]phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 3.2 [1] |
| N-Butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-(2-Methoxy-ethyl)thiophene-2-sulfonamide | Ki | 86.0 [1] |
| 1-Butyl-3-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylurea | Ki | 13.0 [1] |
| N-[2-[4-[[3-Butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-fluorobenzamide | IC50 | 2.0 [1] |
| Tert-butyl N-[2-[4-[[1-[2-bromo-5-(pentanoylamino)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.2 [1] |
| Tert-butyl N-[2-[4-[[1-[5-benzamido-2-(trifluoromethyl)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 5.3 [1] |
| 4-Bromo-N-butyl-3-[4-[[4-[2-[(2,5-dichlorobenzoyl)sulfamoyl]phenyl]-2-fluorophenyl]methyl]-5-oxo-3-propyl-1,2,4-triazol-1-yl]benzamide | IC50 | 2.0 [1] |
| l-Histidyl-l-prolyl-l-phenylalanine | Ki | 10000.0 [1] |
| N-Butyloxycarbonyl-2-(4-imidazol-1-ylmethylphenyl)-4-butylbenzenesulfonamide | Ki | 5.0 [1] |